Eating foods with artificial trans fats raises the bad cholesterol and lowers the good cholesterol, making heart disease more likely.
Scientific Claim
Industrial trans-fatty acids (iTFAs) are associated with elevated low-density lipoprotein cholesterol (LDL-C), elevated triglycerides, elevated lipoprotein(a), and reduced high-density lipoprotein cholesterol (HDL-C) in human populations, contributing to an atherogenic lipid profile that increases cardiovascular disease risk.
Original Statement
“Available data suggest that iTFAs... were associated with elevated low-density lipoprotein cholesterol (LDL-C), triglycerides, and lipoprotein (a), reduced high-density lipoprotein cholesterol (HDL-C)...”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is a narrative review of observational and animal data; it cannot prove causation. The use of 'associated with' is required, not definitive language like 'cause'.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aIn EvidenceThe magnitude and consistency of the association between iTFA intake and changes in LDL-C, HDL-C, and Lp(a) across diverse populations.
The magnitude and consistency of the association between iTFA intake and changes in LDL-C, HDL-C, and Lp(a) across diverse populations.
What This Would Prove
The magnitude and consistency of the association between iTFA intake and changes in LDL-C, HDL-C, and Lp(a) across diverse populations.
Ideal Study Design
A systematic review and meta-analysis of 20+ prospective cohort studies with validated dietary assessments (e.g., FFQ + biomarkers) in adults aged 30–75, measuring plasma phospholipid iTFA levels and longitudinal changes in LDL-C, HDL-C, and Lp(a) over 5–10 years, adjusting for saturated fat, sugar, and BMI.
Limitation: Cannot prove causation due to residual confounding from overall diet quality.
Randomized Controlled TrialLevel 1bIn EvidenceCausal effect of replacing dietary fats with iTFAs on lipid biomarkers in controlled settings.
Causal effect of replacing dietary fats with iTFAs on lipid biomarkers in controlled settings.
What This Would Prove
Causal effect of replacing dietary fats with iTFAs on lipid biomarkers in controlled settings.
Ideal Study Design
A double-blind, placebo-controlled RCT of 150 adults with normal lipids, randomized to consume 2% of daily energy from iTFAs (elaidic acid) vs. cis-unsaturated fats for 8 weeks, with primary outcomes of fasting LDL-C, HDL-C, and Lp(a) measured by standardized assays.
Limitation: Short duration limits assessment of long-term cardiovascular outcomes.
Prospective Cohort StudyLevel 2bIn EvidenceLong-term association between dietary iTFA intake and incident cardiovascular events mediated by lipid changes.
Long-term association between dietary iTFA intake and incident cardiovascular events mediated by lipid changes.
What This Would Prove
Long-term association between dietary iTFA intake and incident cardiovascular events mediated by lipid changes.
Ideal Study Design
A prospective cohort of 10,000 adults aged 40–65 followed for 15 years, with repeated dietary assessments and serial lipid measurements, linking baseline iTFA intake (via biomarkers) to incident myocardial infarction or stroke.
Limitation: Cannot isolate iTFA effects from other dietary or lifestyle confounders.
Evidence from Studies
Supporting (1)
This study says that artificial trans fats in processed foods make bad cholesterol go up, good cholesterol go down, and increase heart disease risk — which is exactly what the claim says.